全文获取类型
收费全文 | 2593篇 |
免费 | 181篇 |
国内免费 | 13篇 |
专业分类
耳鼻咽喉 | 35篇 |
儿科学 | 73篇 |
妇产科学 | 112篇 |
基础医学 | 352篇 |
口腔科学 | 38篇 |
临床医学 | 420篇 |
内科学 | 478篇 |
皮肤病学 | 38篇 |
神经病学 | 275篇 |
特种医学 | 45篇 |
外科学 | 226篇 |
综合类 | 25篇 |
一般理论 | 2篇 |
预防医学 | 316篇 |
眼科学 | 74篇 |
药学 | 135篇 |
中国医学 | 3篇 |
肿瘤学 | 140篇 |
出版年
2023年 | 14篇 |
2022年 | 32篇 |
2021年 | 79篇 |
2020年 | 44篇 |
2019年 | 50篇 |
2018年 | 73篇 |
2017年 | 50篇 |
2016年 | 67篇 |
2015年 | 77篇 |
2014年 | 99篇 |
2013年 | 150篇 |
2012年 | 187篇 |
2011年 | 196篇 |
2010年 | 99篇 |
2009年 | 108篇 |
2008年 | 152篇 |
2007年 | 157篇 |
2006年 | 182篇 |
2005年 | 162篇 |
2004年 | 164篇 |
2003年 | 156篇 |
2002年 | 138篇 |
2001年 | 12篇 |
2000年 | 17篇 |
1999年 | 20篇 |
1998年 | 28篇 |
1997年 | 19篇 |
1996年 | 16篇 |
1995年 | 16篇 |
1994年 | 12篇 |
1993年 | 13篇 |
1992年 | 12篇 |
1991年 | 13篇 |
1990年 | 10篇 |
1989年 | 13篇 |
1988年 | 11篇 |
1987年 | 7篇 |
1986年 | 8篇 |
1985年 | 8篇 |
1984年 | 16篇 |
1983年 | 15篇 |
1982年 | 10篇 |
1981年 | 7篇 |
1980年 | 10篇 |
1979年 | 5篇 |
1978年 | 5篇 |
1977年 | 5篇 |
1976年 | 10篇 |
1974年 | 6篇 |
1967年 | 6篇 |
排序方式: 共有2787条查询结果,搜索用时 15 毫秒
21.
Lisa Marlene Krassuski Sibylle Kautz-Freimuth Vera Vennedey Kerstin Rhiem Rita K. Schmutzler Stephanie Stock 《Geburtshilfe und Frauenheilkunde》2021,81(6):679
Introduction Women with a pathogenic BRCA1/2 mutation have a markedly increased lifetime risk of developing breast and/or ovarian cancer. The current preventive treatment alternatives that are offered are an intensified breast cancer screening programme and risk-reducing operations. Before deciding on one option, medical and personal factors such as life situation and individual preferences must be weighed carefully. Decision aids are used internationally to support BRCA1/2 mutation carriers during their decision-making process. In this study these are analysed structurally for the first time and their applicability to the German context is examined. Material and Methods A systematic literature search in five electronic databases and a manual search were performed. The identified decision aids were evaluated with regard to formal criteria, medical content and quality. The qualitative assessment used the criteria of the International Patient Decision Aid Standards Collaboration (IPDASi v4.0), which examined various dimensions (e.g., information, probabilities, values). Results Twenty decision aids, which were published between 2003 and 2019 in Australia (n = 4), the United Kingdom (n = 3), Canada (n = 2), the Netherlands (n = 2) and the USA (n = 9), were included. Nine focus on BRCA1/2 mutation carriers and eleven include other risk groups. Eighteen include risk-reducing operations as decision options, 14 list screening methods for breast and/or ovarian cancer, and 13 describe the possibility of pharmacological prevention by means of selective oestrogen receptor modulators or aromatase inhibitors. Nine of the 20 decision aids meet fundamental quality criteria (IPDASi v4.0 qualification criteria). Conclusion International decision aids can serve formally as a basis for a German decision aid for BRCA1/2 mutation carriers. Some of them differ markedly in content from the recommendations of German guidelines. Only a few achieve a high quality. Key words: BRCA1, BRCA2, decision aid, familial breast cancer, familial ovarian cancer 相似文献
22.
23.
Standardization and the practice of medicine. 总被引:1,自引:0,他引:1
24.
Klaus Lieb Bernd L. Fiebich Inga Herpfer Michela Mantovani Marlene Lffler Thomas J. Feuerstein 《European neuropsychopharmacology》2005,15(6):641-646
Some studies have demonstrated antidepressant activity of neurokinin-1-receptor antagonists (NK-1-RA) in major depressive disorder. However, the underlying mechanisms of this antidepressant effect are largely unknown. Preclinical studies in rats and mice have suggested that NK-1-RA do increase the neuronal release of serotonin (5-HT). This, however, seems to be compensated by an increased 5-HT reuptake, indicating that NK-1-RA have no inhibitory effect on the 5-HT transporter in rodents. Given the possibility that modulation of neurotransmitter release and reuptake may differ between species, with major differences found between rodents and humans, we investigated for the first time the possible modulatory effect of NK-1-RA on 5-HT uptake in human brain synaptosomes and compared it with the situation in rat cortex. We found that the specific human NK-1-RA L-733060, in contrast to the SSRI fluvoxamine (IC50 = 10− 7.96 M) did not inhibit 5-HT uptake in human brain synaptosomes and did not modulate fluvoxamine-induced 5-HT uptake inhibition at 1 μM. Furthermore, substance P as well as Sar9Met(O2)11SP, as the major agonists at the NK-1-R, did not modulate 5-HT uptake in human brain synaptosomes. Similar results were found in rat cortex synaptosomes by using the rat-specific NK-1-RA WIN51708. These results show that in humans, as in rodents, inhibition of the 5-HT transporter is probably not the underlying mechanism of the assumed antidepressant activity of NK-1-RA. 相似文献
25.
26.
27.
Fernanda Rodrigues Helmo Juliana Reis Machado Camila Souza de Oliveira Guimar?es Vicente de Paula Antunes Teixeira Marlene Ant?nia dos Reis Rosana Rosa Miranda Corrêa 《Disease markers》2013,35(6):939-944
Fetal skin has the intrinsic capacity for wound healing, which is not correlated with the intrauterine environment. This intrinsic ability requires biochemical signals, which start at the cellular level and lead to secretion of transforming factors and expression of receptors, and specific markers that promote wound healing without scar formation. The mechanisms and molecular pathways of wound healing still need to be elucidated to achieve a complete understanding of this remodeling system. The aim of this paper is to discuss the main biomarkers involved in fetal skin wound healing as well as their respective mechanisms of action. 相似文献
28.
29.
30.
Information‐seeking and use of information resources among melanoma patients of German skin cancer centers
下载免费PDF全文
![点击此处可从《Journal der Deutschen Dermatologischen Gesellschaft》网站下载免费的PDF全文](/ch/ext_images/free.gif)